Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,478 | 105 | 96.3% |
| Education | $56.26 | 2 | 3.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $352.89 | 25 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $202.85 | 21 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $153.61 | 8 | $0 (2021) |
| Harmony Biosciences LLC | $97.96 | 5 | $0 (2022) |
| Amgen Inc. | $88.44 | 5 | $0 (2022) |
| SK Life Science, Inc. | $86.64 | 5 | $0 (2022) |
| UCB, Inc. | $85.83 | 5 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $78.46 | 6 | $0 (2022) |
| Supernus Pharmaceuticals, Inc. | $77.43 | 6 | $0 (2022) |
| Lilly USA, LLC | $73.07 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $83.58 | 5 | ABBVIE INC. ($49.37) |
| 2022 | $845.49 | 63 | ABBVIE INC. ($243.73) |
| 2021 | $514.84 | 32 | Biohaven Pharmaceuticals, Inc. ($153.61) |
| 2020 | $63.75 | 5 | Akcea Therapeutics, Inc. ($22.38) |
| 2019 | $26.19 | 2 | Teva Pharmaceuticals USA, Inc. ($14.56) |
All Payment Transactions
107 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/15/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug), Ongentys | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Neuropsychiatry | ||||||
| 07/25/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: NEUROSCIENCE | ||||||
| 03/10/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: NEUROSCIENCE | ||||||
| 02/17/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Neurology | ||||||
| 12/21/2022 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Neurology | ||||||
| 12/12/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: NEUROSCIENCE | ||||||
| 11/30/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $10.82 | General |
| Category: PRIMARY CARE | ||||||
| 11/28/2022 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Central Nervous System | ||||||
| 11/21/2022 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Neurology | ||||||
| 11/16/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: NEUROSCIENCE | ||||||
| 11/09/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $10.90 | General |
| Category: PRIMARY CARE | ||||||
| 11/07/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: NEUROSCIENCE | ||||||
| 11/03/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: PRIMARY CARE | ||||||
| 10/31/2022 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: CNS | ||||||
| 10/25/2022 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Neurology | ||||||
| 10/20/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.57 | General |
| Category: NEUROSCIENCE | ||||||
| 10/12/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: PRIMARY CARE | ||||||
| 10/06/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2022 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $22.48 | General |
| 09/29/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: PRIMARY CARE | ||||||
| 09/28/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $2.12 | General |
| Category: PRIMARY CARE | ||||||
| 09/26/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: PRIMARY CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 293 | 320 | $81,529 | $30,000 |
| 2022 | 4 | 151 | 206 | $38,884 | $15,165 |
| 2021 | 4 | 155 | 192 | $38,936 | $16,184 |
| 2020 | 5 | 147 | 173 | $32,999 | $11,673 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 88 | 108 | $22,896 | $9,382 | 41.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 78 | 78 | $25,974 | $9,144 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 76 | 83 | $11,869 | $5,260 | 44.3% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 15 | 15 | $12,690 | $3,588 | 28.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 36 | 36 | $8,100 | $2,626 | 32.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 64 | 100 | $14,100 | $5,905 | 41.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 40 | 59 | $12,213 | $4,620 | 37.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 27 | 27 | $8,451 | $3,003 | 35.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 20 | 20 | $4,120 | $1,636 | 39.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 59 | 78 | $16,146 | $7,049 | 43.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 47 | 65 | $9,165 | $4,126 | 45.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 33 | 33 | $10,329 | $3,822 | 37.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 16 | 16 | $3,296 | $1,187 | 36.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 31 | 31 | $9,703 | $3,478 | 35.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 53 | 68 | $9,588 | $3,262 | 34.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 28 | 37 | $7,659 | $2,962 | 38.7% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 24 | 24 | $4,944 | $1,635 | 33.1% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 11 | 13 | $1,105 | $336.98 | 30.5% |
About Dr. Regina Raab, M.D
Dr. Regina Raab, M.D is a Neurology healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1851443378.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Regina Raab, M.D has received a total of $1,534 in payments from pharmaceutical and medical device companies, with $83.58 received in 2023. These payments were reported across 107 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,478).
As a Medicare-enrolled provider, Raab has provided services to 746 Medicare beneficiaries, totaling 891 services with total Medicare billing of $73,022. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Lexington, KY
- Active Since 01/17/2007
- Last Updated 01/03/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1851443378
Products in Payments
- NURTEC ODT (Drug) $356.46
- UBRELVY (Drug) $179.74
- QULIPTA (Drug) $173.15
- Wakix (Drug) $97.96
- Aimovig (Biological) $88.44
- Briviact (Drug) $85.83
- KYNMOBI (Drug) $66.80
- TROKENDI XR (Drug) $64.49
- NUPLAZID (Drug) $58.95
- EMGALITY (Drug) $57.49
- TOSYMRA (Drug) $52.15
- AJOVY (Biological) $29.82
- INGREZZA (Drug) $28.64
- TEGSEDI (Drug) $22.38
- GOCOVRI (Drug) $18.54
- AMYVID (Drug) $15.58
- AUSTEDO (Drug) $14.56
- OXTELLAR XR (Drug) $12.94
- APTIOM (Drug) $11.66
- Reveal LINQ (Device) $11.63
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Lexington
Dr. Nicole Everman, M.d, M.D
Neurology — Payments: $506,986
Toufic Fakhoury, Md, MD
Neurology — Payments: $393,864
Larry Goldstein, Md, MD
Neurology — Payments: $28,134
Jagannadha Avasarala, Md, Phd, MD, PHD
Neurology — Payments: $26,770
Fred Odago, Md, MD
Neurology — Payments: $22,752
Sharoon Qaiser, M.d, M.D
Neurology — Payments: $19,615